HAP’s Achievement Award Spotlight: Mercy Home Health
August 26, 2019
Reducing readmissions is a top priority for hospitals all across Pennsylvania. Mercy Home Health is making award-winning progress with their IV Diuretic Program to improve disease management and reduce hospital readmissions.
Mercy moved forward with a plan to provide patients with a better quality of life, while also reducing avoidable hospital readmissions by empowering patients with congestive heart failure (CHF) to receive intravenous (IV) diuretic therapy at home.
Due to transportation issues and the scarcity of outpatient IV diuretic services, many of Mercy Home Health’s patients with CHF lacked access to treatment in their neighborhoods and communities. Mercy Home Health established an interdisciplinary team to provide high-quality IV diuretic therapy in patients’ homes.
Launched during April 2018, the CHF IV Diuretic Program:
- Includes home-health policies and competencies for staff
- Installs telehealth equipment in patients’ homes
- Educates patients about how to use the equipment to track daily vital signs
- Includes physician management and home care nurse visits to start patients’ IV diuretic protocol when treatment is needed
- Helps patients make follow-up post-treatment appointments with cardiologists
Mercy’s efforts resulted in promising data. As of February 2019, 10 patients had entered the program and experienced an average 5.5 percent 30-day readmission rate, as compared to an overall 13 percent readmission rate for Pennsylvania patients who do not receive telehealth services.
Congratulations to Mercy Home Health for reducing hospital readmissions and winning a HAP Achievement Award. Learn more about this effort as well as other 2019 award-winning programs at HAP’s website.
Questions about the HAP Achievement Awards may be directed to HAP Member Services at (717) 561-5359